Replies to post #156661 on Biotech Values

[genisi]

The only mention of the Procognia-UniTargeting FoB collaboration update (in English), is this words deficient paragraph:

Procognia soared 19.6% Thursday after the biotechnology company said for laboratory results of cells it has developed for growing a generic version of Abbot Labs Humira treatment for rheumatoid arthritis and other ailments.

http://www.haaretz.com/business/market-report-wall-street-lifts-tel-aviv.premium-1.502232

PS good catch on my Scandinavian confusion.